The Inhibitory Response to PI3K/AKT Pathway Inhibitors MK-2206 and Buparlisib Is Related to Genetic Differences in Pancreatic Ductal Adenocarcinoma Cell Lines
暂无分享，去创建一个
M. Lerch | H. Murua Escobar | N. Ameziane | C. Junghanss | D. Zechner | F. Weiss | S. Sender | Ruslan Al-Ali | Susann H. Krake | A. Sekora | P. Bauer | Yixuan Ma | Alisha Parveen | Weibo Kong | Mandy Radefeldt | Anett Sekora